Hives from Wegovy: causes, what to watch for, and when to act

What clinical evidence and MHRA guidance say about skin reactions

The STEP 1 trial, which assessed semaglutide 2.4mg in over 1,900 adults with obesity over 68 weeks and is published in the New England Journal of Medicine, recorded hypersensitivity reactions including urticaria among adverse events in the active treatment group. The absolute frequency was low relative to gastrointestinal effects, but the signal was consistent enough to be reflected in the medicine's labelling.

Post-marketing surveillance has added to this picture. The MHRA's Yellow Card database continues to receive spontaneous reports of skin reactions from people using semaglutide, and the NHS medicines information page for semaglutide lists urticaria among the reactions for which patients are advised to seek medical advice promptly. That framing matters: the guidance is not "stop immediately" for every rash, but it is not "wait and see" for an extensive or rapidly spreading one either.

The distinction regulators and clinicians draw is between injection-site reactions, which are local, typically appear within an hour of the injection and fade quickly, and systemic hypersensitivity reactions, which spread beyond the injection site and may be accompanied by swelling, flushing or other symptoms. Hives that develop away from the injection site, or that begin there and spread outward, belong in the second category and require a call to your prescriber or NHS 111 the same day.

Injection-site redness versus true urticaria: spotting the difference

A question our prescribers hear most weeks is whether a red, itchy patch near the injection point means the medicine has to stop. In most cases it does not. Localised injection-site reactions are common with subcutaneous medicines; they reflect the mechanical and chemical disturbance of introducing fluid under the skin rather than an immune-mediated rejection of the drug itself. The skin flares, then settles within a few hours, and rotating injection sites (abdomen, thigh and upper arm are all licensed locations) tends to reduce recurrence.

True urticaria looks different. The wheals are raised, pale or pink in the centre, itchy, and can appear anywhere on the body, not only near the pen. They may coalesce into larger patches and can come and go in waves over hours. If you have had urticaria in other contexts before starting Wegovy, tell your prescriber: a background history of atopy does not automatically bar someone from treatment, but it changes the monitoring conversation. You can read more about semaglutide and hives in our dedicated article if you want a deeper comparison of how skin reactions present across different patient groups.

Storage and injection technique are also worth checking. A pen used after an extended period outside the fridge, or one that has been frozen, may degrade in ways that increase local reactivity. The Wegovy SmPC on the eMC sets out exact storage windows; those details live in the patient information leaflet that ships with every pen, and following them precisely is a straightforward way to reduce avoidable reactions.

When hives from Wegovy need urgent attention

Urticaria is occasionally the first visible sign of anaphylaxis, a severe systemic allergic response. The indicators that move a skin reaction from "ring your GP today" into "call 999" territory are: hives spreading rapidly across a large body area, swelling of the face, lips or throat, difficulty swallowing or breathing, a sudden drop in blood pressure causing dizziness or fainting, or abdominal cramping alongside the rash. If any of those features appear, emergency help is the correct response, and the person should not drive themselves.

For reactions that are concerning but not immediately dangerous, NHS 111 can triage appropriately. Your prescriber should be informed regardless; continuing, pausing or stopping Wegovy in the context of a hypersensitivity reaction is a clinical decision, not one to make alone based on how the rash looks at a given moment. Suspected side effects, including skin reactions, can be reported directly via the MHRA Yellow Card scheme, which helps regulators track real-world safety signals across the whole semaglutide-treated population.

People with a documented history of severe allergic reactions to semaglutide or to any excipient in the formulation should not use Wegovy; this contraindication is reviewed during the clinical assessment before a prescription is issued. If you are considering starting treatment and have concerns about allergy history, that conversation belongs at the consultation stage, and it can also help to understand where Wegovy is manufactured and what it contains, since knowing the formulation's origins gives useful context for discussing excipient sensitivities with your prescriber. Our page covering the clinical evidence behind weight loss from Wegovy explains the broader benefit-risk picture that prescribers weigh when assessing suitability.

Managing mild skin reactions and what to tell your prescriber

If you develop localised hives that are not spreading and you have no other symptoms, practical steps while you wait to speak with your prescriber include: applying a cool compress to the affected area, avoiding tight clothing over the site, and taking a non-drowsy antihistamine if you have one available and are not contraindicated. Do not apply topical steroids or antihistamine creams without clinical advice, as reactions can sometimes mask progression. Do not skip or delay your next Wegovy injection on the basis of a mild localised reaction without speaking to your prescriber first; dose timing matters for the titration schedule.

At your next clinical review, describe the rash: when it appeared relative to the injection, how large it was, how long it lasted, whether it was limited to the injection area or spread beyond it, and whether any other symptoms accompanied it. That information helps your prescriber decide whether to adjust the injection site, slow down the titration, or recommend an allergy assessment. You can also find out more about why a Wegovy injection sometimes hurts or reacts differently week to week, which often has practical rather than allergic explanations. If you are looking at treatment for the first time, our Wegovy overview sets out what the medicine involves from the first pen onwards. And if cost has been part of your thinking, our Wegovy price comparison guide explains what a legitimate private prescription should include. When you are ready to discuss your own suitability with a prescriber, you can check your eligibility through a free consultation with our clinical team.